de Ledinghen V, Lusivika-Nzinga C, Bronowicki JP, Zoulim F, et al. Sofosbuvir-based regimens are suboptimal in patients with genotype 2 chronic hepatitis C infection: Real-life experience from the HEPATHER ANRS CO22 cohort. J Viral Hepat 2020 May 21. doi: 10.1111/jvh.13321.
PMID: 32436335